CLOUDR GROUP LTD. (F:H3L) — Market Cap & Net Worth
Market Cap & Net Worth: CLOUDR GROUP LTD. (H3L)
CLOUDR GROUP LTD. (F:H3L) has a market capitalization of $48.69 Million (€41.65 Million) as of May 3, 2026. Listed on the F stock exchange, this Germany-based company holds position #21987 globally and #1948 in its home market, demonstrating a -7.86% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CLOUDR GROUP LTD.'s stock price €0.06 by its total outstanding shares 645718830 (645.72 Million).
CLOUDR GROUP LTD. Market Cap History: 2022 to 2026
CLOUDR GROUP LTD.'s market capitalization history from 2022 to 2026. Data shows change from $1.15 Billion to $48.69 Million (-62.43% CAGR).
CLOUDR GROUP LTD. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CLOUDR GROUP LTD.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of H3L by Market Capitalization
Companies near CLOUDR GROUP LTD. in the global market cap rankings as of May 3, 2026.
Key companies related to CLOUDR GROUP LTD. by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #246 globally with a market cap of $99.71 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #441 globally with a market cap of $59.14 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #570 globally with a market cap of $45.94 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1111 globally with a market cap of $22.95 Billion USD ( AU$32.44 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #246 | McKesson Corporation | NYSE:MCK | $99.71 Billion | $814.02 |
| #441 | Cencora Inc. | NYSE:COR | $59.14 Billion | $304.00 |
| #570 | Cardinal Health Inc | NYSE:CAH | $45.94 Billion | $195.24 |
| #1111 | Sigma Healthcare Ltd | AU:SIG | $22.95 Billion | AU$2.81 |
CLOUDR GROUP LTD. Historical Marketcap From 2022 to 2026
Between 2022 and today, CLOUDR GROUP LTD.'s market cap moved from $1.15 Billion to $ 48.69 Million, with a yearly change of -62.43%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €48.69 Million | -37.98% |
| 2025 | €78.51 Million | -26.76% |
| 2024 | €107.20 Million | -81.91% |
| 2023 | €592.61 Million | -48.32% |
| 2022 | €1.15 Billion | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of CLOUDR GROUP LTD. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $48.69 Million USD |
| MoneyControl | $48.69 Million USD |
| MarketWatch | $48.69 Million USD |
| marketcap.company | $48.69 Million USD |
| Reuters | $48.69 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About CLOUDR GROUP LTD.
ClouDr Group Limited provides supplies and software as a service (SaaS) installation to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions for patients with chronic condition management. The company's integrated in-hospital solution offers an AI-driven extensive hospital SaaS to assist doctors in diagnosis and treatment, and… Read more